Enzalutamide
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Enzalutamide |
| DrugBank ID | DB08899 |
| KG Predictions | 12 |
| DL Predictions (≥0.7) | 375 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 12 knowledge graph predictions and 375 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| familial prostate carcinoma | KG |
| prostate carcinoma | KG |
| prostate cancer | KG |
| familial prostate carcinoma | KG |
| prostate carcinoma | KG |
| prostate cancer | KG |
| familial prostate carcinoma | KG |
| prostate carcinoma | KG |
| prostate cancer | KG |
| familial prostate carcinoma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB08899
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.